Autism spectrum disorder (ASD) is a lifelong disorder. In the UK, risperidone is the only psychotropic medication approved for the management of the behavioural symptoms that may accompany autism. This is a population-based study aimed to provide an evaluation of the changing trend in the ...
Psychotropic medication is a core component of psychiatric treatment, often used in conjunction with psychological and psychosocial interventions. No psychotropic medication has UK marketing authorisation for pregnant or breastfeeding individuals;2nevertheless, most are compatible with use in the perinatal peri...
Autism is a neurological disorder most knowingly characterized by impaired social communicative abilities and repetitive behaviors. One of the lesser known symptoms of autism is problems with sensory integration, and in particular vestibular sensory integration. Sensory integration is the process of taking ...
- 《Journal of Autism & Developmental Disorders》 被引量: 65发表: 2013年 Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study OBJECTIVES: To describe the incidence of recorded mental illness and challenging ...
Autism TCAs are often prescribed off-label for[7]: Chronic pain conditions Migraines Insomnia Mirtazapine is often prescribed off-label for[9]: Insomnia Various anxiety disorders PTSD Migraines Trazodone is also commonly prescribed off-label for insomnia[11]. ...
Using routinely collected primary care data from the UK and nationwide Swedish registries to create a cohort of 3,182,773 children, of which 17,495 were exposed to ASMs in pregnancy, we show that those exposed to valproate were more likely to receive a diagnosis of autism, intellectual ...
Background: Recent systematic investigation of clinical populations of children with autism spectrum disorders (ASD) has identified the presence of co-morbid psychiatric symptoms which are often the target of clinical intervention, including use of psychotropic medication. Frequently, these symptoms include...
Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability JAMA Neurol, 79 (7) (2022), pp. 672-681 Google Scholar 18 K.J. Meador, G.A. Baker, N. Browning, M.J. Cohen, R.L. Bromley, J. Clayton-Smith Fetal antiepileptic drug exposure and...
Risk of having more than one diagnosis of autism spectrum disorder, intellectual disability, or any neurodevelopment disordera after prenatal antiseizure medication (ASM) exposureb. eTable 11. Comparison of regression models for risk of neurodevelopment disordera after antiseizure medication exposure (...
Autism Screening Rates in Toddlers Born During the COVID-19 Pandemic JAMA Network Open Research September 23, 2024 Safety of In Utero Exposure to Buprenorphine + Naloxone vs Buprenorphine Alone JAMA Research August 12, 2024 Select Your Interests Others Also Liked A New Risk Factor for Autism...